ArticleIranian journal of pharmaceutical research : IJPR2021

Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical Trial.

Zahra Nekoukar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.